1. Introduction {#s0005}
===============

In the last few decades, antibiotics have been broadly utilized not only for human therapies, such as curing infectious diseases like COVID-19, transplants, chemotherapy, and surgical interventions, but also for therapeutic and non-therapeutic purposes in aquaculture and animal husbandry and for enhancing crop production [@b0005], [@b0010]. However, the use and overuse as well as the delayed metabolism of antibiotics have led to the inevitable discharge of their residues into aquatic environments, resulting in refractory pollution sources [@b0015]. Conventional wastewater treatment plants (WWTPs) cannot efficiently remove antibiotic residues [@b0020], [@b0025]. This leads to their distribution into ecological systems [@b0030], [@b0035] and eventually into the human body through the food chain or drinking water [@b0040], [@b0045], [@b0050]. Moreover, the long residence times of antibiotic residues in aquatic environments, even at low concentrations, may lead to the propagation of bacteria with antibiotic resistance and even multiple drug resistance, which may cause life-threatening infections [@b0015], [@b0055], [@b0060]. Therefore, developing an effective approach to degrade or remove antibiotic residues from aquatic environments is crucial.

Different methods have been developed to treat antibiotic residues in water and wastewater before their final release into the environment. [Table 1](#t0005){ref-type="table"} summarizes the current main approaches, including traditional techniques and newly developed methods.Table 1Methods for antibiotic degradation or removal in water**TreatmentMaterialsAntibioticOperating conditionsDisadvantagesRef.**Adsorption processesAnionic surfactant sodium dodecyl sulfate (SDS)AmoxicillinAmpicillinContact time: 40 minAgitation speed: 350 rpmTemperature: 40 °CpH: 4Low removal capacities; difficult separation;secondary environmental pollution; unsatisfactory recycling ability[@b0065]KOH-modified biocharNorfloxacinSulfamerazineOxytetracyclineTemperature: 15--35 °CpH 3--9[@b0070]Graphene oxide/cellulose nanofibril hybrid aerogelDoxycyclineChlortetracyclineOxytetracyclineTetracyclineTemperature: 25 °C[@b0075]Pyrogenic carbonaceous materialsCiprofloxacinContact time: 72 hTemperature: 25 °CpH 7.5 and 9.5[@b0080]Clean and dried *Kigelia pinnata* modified with ionic liquidIbuprofenKetoprofenAmpicillinDiclofenacpH 2.5 or 5[@b0085]Manure-derived biocharsLincomycinpH 6 or 10[@b0090]Lanthanum modified diatomiteTetracycline antibioticsContact time: 24 hpH 3--10[@b0095]**TreatmentMaterialsAntibioticOperating conditionsDisadvantagesRef.**Adsorption processesGrape stalkOfloxacinChrysoidinepH 4, 7, and 9Low removal capacities; difficult separation;secondary environmental pollution;unsatisfactory recycling capacity[@b0100]Cleaned and dried *Pachydictyon coriaceum* and *Sargassum hemiphyllum*TetracyclineTemperature: 15--35 °CpH 3--9Salinity: 0--100 mM NaCl[@b0105]Spent mushroom substrateSulfamethyldiazineSulfamethazineSulfathiazoleSulfamethoxazoleTemperature: 15 °CpH 3--11[@b0110]Coagulation/flocculation/sedimentationAmino-acid-modified-chitosan flocculantsNorfloxacinSulfadiazineTylosinTemperature: 25 °CpH 6, 7, 8Antibiotics cannot be completely removed and secondary pollution occurs readily[@b0115]OzonationOzoneAmoxicillinDoxycyclineCiprofloxacinSulfadiazineNeutral pHDemands high equipment and energy costs[@b0120]Ozone/zero-valent ironFlumequineContact time: 1 hInitial pH 2.5Fe (0) dosage: 60 g/LOzone flow rate: 0.25 L/minTemperature: 30 °C[@b0125]**TreatmentMaterialsAntibioticOperating conditionsDisadvantagesRef.**OzonationMedium-high frequency ultrasound and ozoneAmoxicillinMedium-high ultrasonic frequency waves: 575, 861, 1141 kHzpH 7, 10Demands high equipment and energy costs[@b0130]OzoneFlumequineContact time: 6 minTemperature: 25 °CpH 3, 5, 7, 9, 11[@b0135]OzoneOfloxacinTemperature: 25 °CpH: 2, 7, 12[@b0140]Multistage ozone and biological treatment systemAmoxicillinTemperature: 25 °CpH: 10Complex; high operating costs; continuous use is impractical[@b0145]Chemical coagulation and microfiltrationIbuprofenEphedrinePropranololDifferent doses of ZnO nanoparticles: 0.5, 0.7, 1.0, 1.3, 1.5, 1.7 g/LpH 7, 9[@b0150]Electric coagulation and photo-electro-Fenton processMetronidazolepH: 1, 3, 5, 7, 9Metronidazole concentration: 50 mg/LVoltage: 5--30 VH~2~O~2~: 0--0.02 mol/LTemperature: ∼20 °CUV at 230 nmNumber of UV lamps: 1-4[@b0155]**TreatmentMaterialsAntibioticOperating conditionsdisadvantagesRef.**Combined processesA membrane bioreactor (MBR) integrated with solar Fenton oxidationSulfamethoxazoleErythromycinClarithromycinH~2~O~2~: 20--100 mg/LpH: 2.8\[Fe^2+^\]: 5 mg/LComplex; high operating costs; impracticability in continuous use[@b0160]Integrated adsorption-membrane filtration processNorfloxacinOfloxacinpH: 7Temperature: 25 °CUV at 276 nm and 293 nmpressure range: 34.47--172.36 kPa[@b0165]Ultraviolet, chlorination, ozone disinfectionAntibiotic resistance genesChlorine concentrations: 2--32 mg/LOzone concentration: 2--10 mg/LUV (mJ/cm^2^): 10--160[@b0170]Adsorptive magnetic ion exchange resinSulfamethoxazoleTetracyclineAmoxicillinContact time: 30 minTemperature: 25 °CMIEX resin dosage: 5 mL/LAntibiotic: 1000 μg/L[@b0150]Nanofiltration and chlorinationSulfanilamideSulfadiazineSulfamethoxazoleSulfadimethoxineMembrane effective area: 40.92 cm^2^Operating pressure: 5 barTemperature: 25 °CFlow rate: 120--150 mL/minInitial pH: 5.6, 7.2, 10Initial concentration: 2.0 × 10^-5^ M[@b0175]

These current methods can be loosely classified into three types according to the treatment mechanisms or principles involved: physical removal, biological treatment, and chemical degradation. As shown in [Table 1](#t0005){ref-type="table"}, physical methods such as adsorption, sedimentation, flocculation, and filtration only separate the antibiotic residues from the water and generate problematic products such as brine and contaminated adsorbents. Alternatively, biological approaches have recently emerged, and most antibiotic residues in the environment can be removed through this route [@b0180], [@b0185], [@b0190]. However, the artificial introduction of active organisms into aquatic environments may disrupt the ecological balance of their biomes, which may cause irreversible ecosystem damage. Moreover, biological processes suffer from some key disadvantages such as being time-consuming and often unreliable. Therefore, the chemical degradation of antibiotics has gained strong interests.

Different chemical approaches such as ozonation, chlorination, and Fenton's oxidation have been developed for the treatment of antibiotic residues in water, as shown in [Table 1](#t0005){ref-type="table"}. Unfortunately, complete mineralization is difficult to achieve or may otherwise be prohibitively lengthy. In some cases, these methods may kill non-target organisms due to their low selectivity, which causes unintended damages [@b0195], [@b0200]. Additionally, this method incurs high capital and high operating costs. Combinations of physical and chemical degradation processes can significantly reduce the toxicity of treated effluents during the removal of antibiotic residues from water. Nevertheless, these methods are complex and costly [@b0205].

Alternatively, photocatalysis has broad application prospects for environmental remediation due to its unique advantages, including (1) easily-attainable reaction conditions (i.e., near ambient temperature and mostly ambient pressure), the use of oxygen in the air to produce a powerful oxidant, and the use of solar radiation as an energy source; (2) potentially complete decomposition of organic pollutants into innocuous inorganic molecules such as carbon dioxide and water; (3) strong redox ability, low cost, no adsorption saturation, and long durability. Therefore, photocatalysis has increasingly garnered worldwide interest and has been broadly implemented in novel energy extraction and environmental control strategies.

Photocatalysis is an advanced oxidation process that has previously been applied in the treatment of antibiotic residues. As shown in [Fig. 1](#f0005){ref-type="fig"} , less than 40 studies had been published on the photocatalytic treatment of antibiotic residues, prior to 2014. However, a sharply increasing number of publications on this subject have been released thereafter. Substantial progress has been made in recent years; however, photocatalysis still suffers from some key imperfections, including insufficient visible light utilization, rapid annihilation of photogenerated carriers, and incomplete mineralization, all of which strongly restrict its commercial application. A thorough overview concerning the fundamentals, improvement, and modification of strategies and challenges of the photocatalytic treatment of antibiotic residues was yet to be compiled, and therefore, these topics have been comprehensively addressed herein.Fig. 1Number of search results of recent publications addressing the photocatalytic treatment of antibiotic residues using "photocatalytic" and "antibiotic treatment" as keywords (collected from the Web of Science Core Database: March 9, 2020)

This article comprehensively reviews the latest advances in the photocatalytic treatment of antibiotic residues in water. Specifically, the fundamentals of photocatalysis will be introduced. Different strategies will then be summarized and classified, followed by a discussion on the improvement and modification strategies to enhance the photocatalytic degradation of antibiotics. Finally, this review will conclude with a summary of major challenges and key perspectives.

2. Basic principles of photodegradation {#s0010}
=======================================

When a semiconductor is exposed to irradiation with energy beyond its optical band gap, electrons are excited and shifted from its valence band (VB) towards the conduction band (CB), producing an equal number of positively charged holes in the VB. When the potential of VB vs NHE is more positive than $H_{2}O/ \bullet OH{( + 2.72VvsNHE)}$ or ${\text{O}H}^{-}/ \bullet OH{( + 1.89VvsNHE)}$, and the potential of CB vs NHE is more negative than $\text{O}_{2}/ \bullet \text{O}_{2}^{-}($−0.33 V vs NHE), the semiconductor will be able to generate $\bullet OH$ and $\bullet \text{O}_{2}^{-}$. Thereafter, the photoinduced electrons and holes separate and migrate to the surface of the semiconductor, and redox reactions will occur at the reactive site on the semiconductor surface ([Fig. 2](#f0010){ref-type="fig"} ) [@b0210], [@b0215].Fig. 2Schematic representation of the semiconductor photocatalysis process [@b0220]

The reaction mechanisms of semiconductor photocatalysis are typically expressed by the following equations [@b0225], [@b0230]:

Semiconductor $+$ Light Energy (λ$\geq E_{g}$)$\rightarrow$ Semiconductor ($e_{\mathit{cb}}^{-}$ $+$ $h_{\mathit{vb}}^{+}$) (1)

$h_{\mathit{vb}}^{+} +$ $H_{2}O\rightarrow$ $H^{+} + \bullet$OH ($H_{2}{O/ \bullet OH| + 2.72VvsNHE}$) (2)

$h_{\mathit{vb}}^{+}$ $+$ ${\text{O}H}^{-}$ $\rightarrow \bullet$OH (${\text{O}H}^{-}{/ \bullet OH| + 1.89VvsNHE}$) (3)

$e_{\mathit{cb}}^{-}$ $+$ $\text{O}_{2}$ $\rightarrow \bullet \text{O}_{2}^{-}$ ($\text{O}_{2}/ \bullet \text{O}_{2}^{-}|$−0.33 V vs NHE) (4)

Pollutant $+$ Active species $\left( {h_{\mathit{vb}}^{+},e_{\mathit{cb}}^{-}, \bullet OH, \bullet \text{O}_{2}^{-}} \right)\rightarrow$Degradation Products (5)

Through these chemical processes, solar energy can be directly converted and effectively utilized. For instance, Zhao *et al*. [@b0235] successfully prepared ZnSe quantum dot (QD)/g-C~3~N~4~ composites with remarkable photocatalytic properties and utilized them for the photocatalytic degradation of ceftriaxone sodium. Based on the results, $\bullet$OH and h^+^ were found to be the main active materials. The potential reaction mechanisms are described below.

ZnSe QDs/g-C~3~N~4~ $+$ h*v* $\rightarrow$ h^+^ $+$ e^-^

h^+^ $+$ H~2~O $\rightarrow$ H^+^ $+$ •OH

e^-^ $+$ 1/2O~2~ $+$ H^+^ $\rightarrow$ •OH

h^+^ $+$ •OH $+$ Ceftriaxone sodium $\rightarrow$ CO~2~ $+$ H~2~O $+$ other small molecules

However, limited optical utilization and the quick annihilation of photoexcited electron-hole pairs diminish the effects of photocatalytic activity. Photocatalysts are able to overcome these deficits, provided that they meet the following criteria: (1) appropriate spectral absorption range, (2) proper band energy structure for sufficient separation and transport of electron--hole pairs, and (3) adequate active sites for adsorption or reaction [@b0240], [@b0245], [@b0250]. It is essential to satisfy all three of the aforementioned prerequisites to improve photocatalytic efficiency, and abundant efforts have been made to systematically design photocatalysts and optimize photocatalytic dynamics.

3. Strategies for photocatalytic activity improvement {#s0015}
=====================================================

The photocatalytic treatment of antibiotic residues in aquatic environments has recently become the focus of much attention, and diverse strategies have been proposed to improve the photocatalytic efficiency ([Scheme 1](#f0060){ref-type="fig"} ). Examples of such reported strategies are summarized in [Table 2](#t0010){ref-type="table"} .Scheme 1Strategies for photocatalytic efficiency improvementTable 2Summary of previous studies using different strategies to improve photocatalytic degradation of antibiotics**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**VacanciesBiOCl with abundant oxygen vacancies0.5 g/L300-W Xe lamp(λ\>420 nm)Tetracycline hydrochloride10 mg/LApproximately 87% optimum within 2 h[@b0255]VacanciesOxygen vacancy-rich mesoporous ZrO~2~1 g/L300-W Xe lamp(λ\>420 nm)Tetracycline hydrochloride40 mg/LApproximately 80% optimum within 150 h[@b0260]VacanciesBiOBr microspheres with oxygen vacancies1 g/L10-W LED lamp (0.4 mW‧cm^-2^)Tetracycline (TC)20 mg/LApproximately 94% optimum within 90 min[@b0265]VacanciesZnWO~4-x~ nanorods with oxygen vacancy0.2 g/LHg lamp 300-W UV or 300-W Xe lamp (UV-Vis-NIR)Tetracycline20 mg/LApproximately 91% optimum within 90 min[@b0270]VacanciesBi~2~MoO~6~ with oxygen vacancy0.4 g/L300-W Xe lamp(λ\>400 nm)Ciprofloxacin20 mg/LApproximately 55% optimum within 120 min[@b0275]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**DopingCarbon-doped g-C~3~N~4~0.5 g/LSunlightTetracycline20 mg/LApproximately 90% optimum within 90 min[@b0280]DopingP-O co-doped g-C~3~N~4~1 g/L350-W Xe lamp (λ\>420 nm)Enrofloxacin10 mg/LApproximately 90% within 80 min[@b0285]DopingI and K co-doped g-C~3~N~4~2 g/L300-W Xe lamp (λ\>420 nm)Sulfamethoxazole10 mg/LApproximately 99% optimum within 45 min[@b0290]DopingBi^3+^/g-C~3~N~4~0.2 g/L300-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 94% optimum within 30 min[@b0295]DopingCr^3+^/SrTiO~3~1 g/L250-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 70% optimum within 60 min[@b0300]DopingFe^2+^/Fe^3+^ immobilized on TiO~2~/fly-ash cenospheres2 g/L150-W tungsten halogen lamp (λ\>420 nm)Ciprofloxacin10 mg/LApproximately 80% optimum within 60 min[@b0305]DopingCe^3+^ doped Bi~2~O~3~0.6 g/L300-W lamp (visible light)Tetracycline20 mg/LApproximately 89% optimum within 180 min[@b0310]DopingTi^3+^/N co-doped TiO~2~/diatomite granule5 g/L150-W Xenon lamp with a UV light filterTetracycline10 mg/L92% optimum within 150 min[@b0315]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Quantum dotsCQDs modified Bi~2~MoO~6~1 g/L300-W Xe lamp (λ\>400 nm)Ciprofloxacin20 mg/L88% optimum within 2 h[@b0320]Quantum dotsCQDs/BiOBr microspheres1 g/LVisible light irradiationCiprofloxacin1 g/LApproximately 65% optimum within 180 min[@b0325]Quantum dotsTiO~2~/C-dots0.1 g/L-0.5 g/LAverage intensity sunlight irradiation (72 klx)Levofloxacin10 mg/LApproximately 99% optimum within 90 min[@b0330]Quantum dotsZnSe QDs/g-C~3~N~4~Not provided300-W Xe lamp (λ\>400 nm)Ceftriaxone sodiumConcentration not providedApproximately 80% optimum within 120 min[@b0235]Quantum dotsAg~2~O/TiO~2~ quantum dots0.25 g/L400-W halogen bulb (similar to sunlight)Levofloxacin10 mg/LApproximately 81% optimum within 90 min[@b0335]Quantum dotsCQDs/BiOI0.5 g/L300-W Xe lamp (λ\>400 nm)Tetracycline20 mg/LApproximately 70% optimum within 120 min[@b0340]Quantum dotsCQDs/BiOBr0.3 g/L300-W Xe lamp (λ\>400 nm)Tetracycline20 mg/LApproximately 60% optimum within 120 min[@b0345]Quantum dotsMoS~2~ modified Zn-AgIn~5~S~8~ quantum dots0.1 g/L250-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 74% optimum within 4 min[@b0350]Quantum dots3D ZnS-RGO nanospheres1 g/L300-W Hg vapor lampNorfloxacin20 mg/L92% optimum within 4 h[@b0355]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Phase junctionPorous core-shell homojunction0.5 g/LUV lamp (254 nm, 90 W, Philips)Tetracycline hydrochloride50 mg/LApproximately 81% within 300 min[@b0360]Facet junctionCaCu~3~Ti~4~O~12~Co-exposed (001) and (111) facets0.4 g/L300-W Xe lampvisible lightTetracycline0.24 g/LApproximately 99% within 50 min[@b0365]Facet junctionAgBr tetradecahedrons with co-exposed (100) and (111) facets1 g/L500-W halogen tungsten lamp (λ\>420 nm)Sulfadiazine20 mg/LApproximately 90% optimum within 90 min[@b0370]Schottky heterojunctionAg/Ag~2~MoO~4~0.4 g/L500-W Xe lamp (λ\>420 nm)Ciprofloxacin20 mg/LApproximately 99% optimum within 60 min[@b0375]Schottky heterojunctionAg/TiO~2~ (hollow nanosphere)0.5 g/L125-W high-pressure Hg lamp, (λ\>435.8 nm)Metronidazole15 mg/LApproximately 95% optimum within 120 min[@b0380]Schottky heterojunctionBi/BiOBr (nano-flowers)0.8 g/L300-W Xe lamp (λ\>420 nm)Tetracycline hydrochloride Ciprofloxacin and Doxycycline1 g/LApproximately 100% optimum within 30 min[@b0385]Schottky heterojunctionBiOCl-Ag (2D)1.0 g/L200-W Xe arc lamp (λ\<420 nm)Sulfonamides10 mg/LApproximately 80% optimum within 5 h[@b0390]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Schottky heterojunctionAg/Bi~3~O~4~Cl0.5 g/L250-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 94% optimum within 120 min[@b0395]Schottky heterojunctionAg/CCN0.5 g/L300-W Xe lamp (λ\>420 nm)Tetracycline10 mg/L75% optimum within 15 min[@b0400]Schottky heterojunctionPt/g-C~3~N~4~0.5 g/L300-W Xe lamp (λ\>400 nm)Tetracycline hydrochloride20 mg/LApproximately 84% optimum within 40 min[@b0405]Schottky heterojunctionBi (Spheres)/g-C~3~N~4~0.5 g/L300-W Xe lamp (λ\>420 nm)Amoxicillin100 mg/LApproximately 5% optimum within 4 hours[@b0410]Schottky heterojunctionW-doped BaTiO~3~0.2 g/LVisible light irradiationTetracycline20 mg/LApproximately 80% optimum within 3 h[@b0415]Schottky heterojunctionFe, Co, Ni, Fe-Co-, and Fe-Ni-doped ZnO0.6 g/L300-W Xe lamp (λ=365 nm)Oxytetracycline20 mg/LApproximately 87% optimum within 2 h[@b0420]Schottky heterojunctionPt/Bi/TiO~2~1 g/L300-W halogen-tungsten lamp (λ\>420 nm)Amoxicillin10 mg/LApproximately 87% optimum within 2 h[@b0425]Schottky heterojunctionAu/Pt/g-C~3~N~4~1 g/L500-W Xe lamp (λ\>400 nm)Tetracycline hydrochloride20 g/LApproximately 90% optimum within 3 h[@b0430]Schottky heterojunction0D Bi nanodots/2D Bi~3~NbO~7~ nanosheets300-W Xe lamp (λ\>400 nm)Ciprofloxacin10 mg/LApproximately 86% optimum within 120 min[@b0435]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Type Ⅱ heterojunctionAgI/BiVO~4~0.3 g/L300-W Xe lamp (λ\>420 nm)Tetracycline (TC)20 mg/LApproximately 94% optimum within 1 h[@b0440]Type Ⅱ heterojunction3D porous CdS/TiO~2~1 g/L300-W Xe lamp (λ\>420 nm)Tetracycline and oxytetracycline (OTC)40 mg/LApproximately TC: 67% and OTC: 81% optimums within 50 min[@b0445]Type Ⅱ heterojunctionMgFe~2~O~4~/MoS~2~Radiation intensity: 47 mW/cm^2^Tetracycline10 mg/LApproximately 92% optimum within 120 min[@b0450]Type Ⅱ heterojunctionZnWO~4~-CdS1 g/L300-W Xe lamp (λ\>420 nm)Ciprofloxacin15 mg/LApproximately 90% optimum within 1 h[@b0455]Type Ⅱ heterojunctionZnO\@ZnS nanorod500-W Xe lampTetracycline10 mg/mLApproximately 80% within 140 min[@b0460]Type Ⅱ heterojunctionMoS~2~/PbBiO~2~I0.3 g/L300-W Xe lamp (λ\>400 nm)Ciprofloxacin10 mg/LApproximately 80% optimum within 6 h[@b0465]Type Ⅱ heterojunctionBi~2~SiO~5~/Bi~12~SiO~20~1 g/L100-W high-pressure Hg lampTetracycline10 mg/LApproximately 79% optimum within 30 min[@b0470]Type Ⅱ heterojunctionSrTiO~3~/Fe~2~O~3~1 g/L250-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 83% optimum within 140 min[@b0475]Type Ⅱ heterojunctionp-C~3~N~4~/f-BiOBr1 g/L250-W Xe lamp (λ\>400 nm)Tetracycline30 mg/LApproximately 94% optimum within 300 min[@b0480]Type Ⅱ heterojunctionBi~2~O~7~Sn~2~-Bi~7~O~9~I~3~1 g/LHalogen lamp as simulated solar lightTetracycline35 mg/L80% optimum within 90 min[@b0485]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Type Ⅱ heterojunctionNiFe~2~O~4~/Bi~2~O~3~1 g/L150-W xenon lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 91% optimum within 90 min[@b0490]Type Ⅱ heterojunctionBiVO~4~/rGO0.9 g/L250-W Xe lamp (λ\>420 nm)Tetracycline25 mg/L99% optimum within 90 min[@b0495]Type Ⅱ heterojunctionSrTiO~3~ nanocube coated CdS microsphere1 g/L250-W Xe lamp (λ\>400 nm)Ciprofloxacin10 mg/LApproximately 94% optimum within 120 min[@b0500]Type Ⅱ heterojunctiong-C~3~N~4~/BiPO~4~0.3 g/L250-W high-pressure Hg lampCiprofloxacin10 mg/LApproximately 97% optimum within 120 min[@b0505]Type Ⅱ heterojunctiong-C~3~N~4~/Ag~3~PO~4~300-W Xe lamp (λ\>400 nm)CiprofloxacinConcentration not providedApproximately 67% optimum within 15 min[@b0510]Type Ⅱ heterojunctionIn~2~S~3~/NaTaO~3~0.5 g/L300-W Xe lampTetracycline hydrochloride10 mg/LApproximately 80% optimum within 180 min[@b0515]Type Ⅱ heterojunctionPolyaniline/Bi~4~O~5~Br~2~0.4 g/LVisible light(λ＞420 nm)Ciprofloxacin10 mg/LTetracycline20 mg/LCIP: 99% optimum within 50 min, TC: approximately 86% optimum within 240 min[@b0520]Type Ⅱ heterojunctionCdS nanoparticles/porous carbon polyhedrons1 g/L300-W Xe lamp (λ\>420 nm)Cephalexin20 mg/LApproximately 90% optimum within 90 min[@b0525]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Type Ⅱ heterojunctionMicrosphere-like In~2~S~3~/InVO~4~0.5 g/L300-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 71% optimum within 60 min.[@b0530]Type Ⅱ heterojunctiong-C~3~N~4~/Bi~4~O~5~Br~2~0.5 g/L300-W Xe arc lampCiprofloxacin10 mg/LApproximately 67% optimum within 150 min[@b0535]Type Ⅱ heterojunctionBi~2~WO~6~/g-C~3~N~4~1 g/L300-W Xe lamp UV lightCeftriaxone sodium10 mg/LApproximately 94% optimum within 120 min[@b0540]Type Ⅱ heterojunctionFlower-root shaped Bi~2~O~3~/Bi~2~MoO~6~0.4 g/L500-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 70% optimum within 190 min[@b0545]Type Ⅱ heterojunctionCovalent triazine framework modified BiOBr nanoflake0.2 g/L500-W Xe lampTetracycline10 mg/LCiprofloxacin10 mg/LApproximately TC: 90% and CIP: 60% optimums within 50 min[@b0550]Type Ⅱ heterojunctionmpg-C~3~N~4~ and Bi~2~WO~6~ nest-like structure300-W Xe lamp (λ\>420 nm)Tetracycline hydrochloride50 mg/LApproximately 75% optimum within 120 min[@b0555]Type Ⅱ heterojunctionTiO~2~ nanoparticle/SnNb~2~O~6~ nanosheet heterojunctions1 g/L500-W tungsten lampTetracycline hydrochloride35 mg/LApproximately 76% optimum within 240 min[@b0560]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Type Ⅱ heterojunctionBi~4~Ti~3~O~12~/BiOCl (2D/0D) composite300-W Xe lampTetracycline hydrochloride20 mg/LApproximately 84% optimum within 150 min[@b0565]Type Ⅱ heterojunction2D-2D g-C~3~N~4~/Bi~4~O~5~Br~2~0.1 g/L300-W Xe lamp (λ\>400 nm)Ciprofloxacin10 mg/LApproximately 50% optimum within 30 min[@b0570]Type Ⅱ heterojunction2D/2D Bi~4~Ti~3~O~12~/I-BiOCl0.375 g/L350-W Xe arc lamp (λ\>420 nm)Ciprofloxacin10 mg/LTetracycline hydrochloride10 mg/LApproximately 90% optimum within 120 min[@b0575]Type Ⅱ heterojunctionCarbon-doped carbon nitride/Bi~12~O~17~Cl~2~1 g/L300-W Xe lamp (λ\>420 nm)Tetracycline20 mg/L94% optimum within 60 min[@b0580]Type Ⅱ heterojunctionCuBi~2~O~4~/CuO1 g/LVisible light(λ＞400 nm)Metronidazole50 mg/L36% optimum within 120 min[@b0230]p-n heterojunctionp-n type BiOCl/titanium phosphate nanoplates0.4 g/L300-W Xe lampCiprofloxacin5 mg/LApproximately 100% within 5 min[@b0585]p-n heterojunctionp-n type CoO/g-C~3~N~4~0.5 g/L300-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 90% within 60 min[@b0590]p-n heterojunctionp-n type Cu~2~O/SrTiO~3~1 g/L150-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 79% within 100 min[@b0595]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**p-n heterojunctionp-n type flower-like BiOCl/BiOCOOH p-n1 g/L300-W Xe lamp simulated sunlightTetracycline20 mg/LApproximately 80% within 60 min[@b0600]p-n heterojunctionp-n type Ag~2~O/g-C~3~N~4~1 g/L500-W Xe lamp (λ\>400 nm)Tetracycline hydrochloride20 mg/LApproximately 94% within 3 h[@b0605]p-n heterojunctionp-n type Co~3~O~4~-C~3~N~4~0.5 g/LSunlightTetracycline48 mg/LApproximately 97% within 180 min[@b0610]p-n heterojunctionp-n type 3D flower-like BiOBr/Bi~2~SiO~5~1 g/L300-W Xe lamp (λ\>420 nm)Tetracycline20 mg/L91% within 120 min[@b0615]p-n heterojunctionn-p type SnO~2~ nanoparticles/BiOI1 g/L300-W Xe lamp (λ\>420 nm)Oxytetracycline hydrochloride10 mg/LApproximately 94% optimum within 90 min[@b0620]p-n heterojunctionp-n type N-graphene QDs-BiOI/MnNb~2~O~6~0.5 g/L250-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 87% optimum within 60 min[@b0625]p-n heterojunctionp-n type Fe~3~O~4~ quantum dots modified BiOCl/BiVO~4~300-W Xe lamp (λ\>420 nm)Sulfamethoxazole (SMX, 5 mg/L), TC (20 mg/L), norfloxacin (NOR, 10 mg/L), and CIP (10 mg/L)SMX: 91% within 90 min, TC: 87% within 30 min, NOR: 89% within 60 min, CIP: 87% within 90 min[@b0630]Double heterojunctionCDs/MoS~2~/TiO~2~ nanobelt0.5 g/L250-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 82% within 3 h[@b0635]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Double heterojunction(g-C~3~N~4~)-ZnO/halloysite nanotubes (HNTs)1 g/L350-W Xe arc lampTetracycline20 mg/LApproximately 87% optimum within 60 min[@b0640]Double heterojunctionUltrathin g-C~3~N~4~ nanosheets coupled with amorphous Cu doped FeOOH nanoclusters as 2D/0D heterogeneous catalysts0.2 g/L500-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 90% within 40 min[@b0645]Double heterojunction2D/2D/2D CoAl-LDH/g-C~3~N~4~/RGO ternary heterojunction300-W halogen lamp visible-light irradiationTetracycline20 mg/LApproximately 100% optimum within 60 min[@b0650]Double heterojunctionAg-AgVO~3~/g-C~3~N~4~0.2 g/L300-W Xe lamp (λ\>410 nm)Tetracycline30 mg/LApproximately 84% optimum within 120 min[@b0655]Double heterojunctionZnFe~2~O~4~/Ag/Ag~3~VO~4~1 g/LVisible-light irradiationTetracycline10 mg/LApproximately 60% within 10 min[@b0660]Double heterojunctionNiS and MoS~2~ nanosheet co-modified g-C~3~N~4~ ternary heterostructure1 g/L250-W metal halide lamp (λ\>400 nm)Tetracycline10 mg/LCiprofloxacin10 mg/LApproximately CIP: 71% and TC: 96% optimums, within 120 min[@b0665]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Double heterojunctionAgCl/Ag~3~PO~4~/ g-C~3~N~4~1 mg/LVisible-light irradiation (λ\>400 nm)Sulfamethoxazole50 mg/LApproximately 100% optimum within 90 min[@b0670]Double heterojunction3D Ag~3~PO~4~/TiO~2~\@MoS~2~0.5 g/L800-W Xe arc lampOTC 5 mg/LENR 5 mg/LApproximately OTC: 75%, ENR: 92% within 10 min[@b0675]Double heterojunctionBi~2~O~3~/BiOCl supported on graphene sand (BO/BOC/GSC) composite (BO/BOC/CT)0.5 g/LSolar light intensity (35 × 103± 1000 lx)Oxytetracycline46 mg/LAmpicillin37 mg/LBO/BOC/GSC: approximately 90% for AMP and OTCBO/BOC/CT: approximately 80% for AMP and OTC[@b0680]Double heterojunctionCore-shell structured Fe~3~O~4~\@SiO~2~\@CdS0.2 g/L1000-W tungsten-halide lamp (Philips) (λ\>420 nm)Tetracycline100 mg/LApproximately 80% optimum within 21 min[@b0685]Double heterojunctionRGO-CdS/ZnS0.5 g/L300-W Xe lamp (λ\>420 nm)Tetracycline15 mg/LApproximately 90% optimum in 60 min[@b0690]Double heterojunctionTiO~2~/Bi~2~WO~6~/carbon fibers3 g/L300-W Xe lamp (λ\>400 nm)Tetracycline hydrochloride10 mg/LApproximately 95% optimum within 60 min[@b0695]Z-scheme heterojunctionZ-scheme beta-Bi~2~O~3~\@g-C~3~N~4~ core/shell nanocomposite250-W Xe lamp (λ\>420 nm)Tetracycline10 mg/LApproximately 80% optimum within 50 min[@b0700]Z-scheme heterojunctionZ-scheme WO~3~-g-C~3~N~4~0.5 g/L300-W Xe arc lamp (1.5 AM solar simulator)Sulfamethoxazole10 mg/LApproximately 92% optimum within 4 h[@b0705]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Z-scheme heterojunctionZ-scheme AgI nanoparticle-sensitized Bi~5~O~7~I microspheres0.5 g/L300-W Xe lamp(λ\>400 nm)TC (20 mg/L), DTC (10 mg/L), OTC (10 mg/L), or CIP (10 mg/L)Approximately TC: 95%, DTC: 90%, OTC: 80% and CIP: 90% optimums within 40 min[@b0710]Z-scheme heterojunctionZ-scheme CdTe/TiO~2~0.8 g/L400-W halogen lamp (λ\>400 nm)Tetracycline hydrochloride20 mg/LApproximately 78% optimum within 30 min[@b0715]Z-scheme heterojunctionType II AgI/CuBi~2~O~4~Z-scheme AgBr/CuBi~2~O~4~0.5 g/L300-W Xe lamp(λ\>420 nm)Tetracycline10 mg/LApproximately Type II catalyst: 80% and Z-scheme catalyst:90% optimums within 30 min[@b0720]Z-scheme heterojunctionZ-scheme mesoporous Sn~3~O~4~ nanoclusters/g-C~3~N~4~ nanosheets0.5 g/L500-W Xe lamp(λ\>420 nm)Tetracycline hydrochloride10 mg/LApproximately 72% optimum within 120 min[@b0725]Z-scheme heterojunctionZ-scheme Bi~3~TaO~7~ QDs/g-C~3~N~4~ nanosheets (NSs)0.5 g/LLED lamp(λ=420 nm, 86 W)CIP and CPX10 mg/LApproximately CIP: 91%, CPX: 77% CPX within 120 min[@b0730]Z-scheme heterojunctionZ-scheme WO~3~ nanosheet/K^+^Ca~2~Nb~3~O~10~^-^ ultrathin nanosheet1 g/L250-W xenon lamp as simulated sunlight (no filters).Tetracycline hydrochloride35 mg/LApproximately 86% optimum within 120 min[@b0735]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Z-scheme heterojunctionZ-scheme AgI/BiOBr0.5 g/L300-W Xe lamp (λ\>420 nm)Ciprofloxacin10 mg/LApproximately 91% optimum within 1 h[@b0740]Z-scheme heterojunctionZ-scheme Ag~3~PO~4~/g-C~3~N~4~0.05 g/L300-W Xe lamp (λ\>400 nm)Sulfamethoxazole1 mg/LApproximately 99% optimum within 90 min[@b0745]Z-scheme heterojunctionZ-scheme CdS-Au-BiVO~4~ (010)0.5 g/L300-W Xe lamp (λ\>420 nm)Tetracycline10 mg/L91% optimum within 90 min[@b0750]Z-scheme heterojunctionZ-scheme BiVO~4~/Ag/Cu~2~O0.4 g/L300-W Xe lamp (λ\>420 nm)Tetracycline20 mg/LApproximately 91% optimum within 90 min[@b0755]Z-scheme heterojunctionZ-scheme ZnFe~2~O~4~/Ag/PEDOT0.2 g/L250-W xenon lamp (1.8×105 lux)Tetracycline20 mg/LApproximately 72% optimum within 120 min[@b0760]Z-scheme heterojunctionOrganic-inorganic Z-scheme PANI/Ag/Ag~2~MoO~4~∼ 0.2 g/L40-W UV tube (Phillips)Ciprofloxacin3 mg/LApproximately 100% optimum within 40 min[@b0765]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Z-scheme heterojunctionZ-scheme (001) BiOCl-Au-CdS1 g/L300-W Xe lamp (AM 1.5)Sulfadiazine20 mg/LApproximately 91% optimum within 4 h[@b0770]Z-scheme heterojunctionZ-scheme iodine vacancy-rich BiOI/Ag\@AgI0.3 g/L300-W Xe lamp (λ\>420 nm)Tetracycline20 mg/LApproximately 86% optimum within 60 min[@b0775]Z-scheme heterojunctionZ-scheme Ag~2~CO~3~/Ag/WO~3~0.5 g/L300-W Xe lamp (λ\>420 nm)CIP and TC10 mg/LApproximately CIP: 84% and TC: 81% optimums within 90 min[@b0780]Z-scheme heterojunctionZ-scheme AgI/Ag/Bi~3~TaO~7~0.5 g/L300-W Xe lamp (visible light)Sulfamethoxazole5 mg/LApproximately 98% optimum within 100 min[@b0785]Z-scheme heterojunctionZ-scheme MIL-53(Fe)/Ag/g-C~3~N~4~80 mg/LVisible lightClioquinol10 mg/L95% optimum within 100 min[@b0790]Z-scheme heterojunctionZ-scheme CeVO~4~/3D RGO aerogel/BiVO~4~0.5 g/L500-W Xe lampTetracycline20 mg/LApproximately 100% optimum within 60 min[@b0795]Z-scheme heterojunctionTCPP/rGO/Bi~2~WO~6~0.3 g/L300-W Xe lamp (λ\>420 nm)Tetracycline15 mg/LApproximately 84% optimum within 60 min[@b0800]Z-scheme heterojunctionZ-scheme Ag~3~PO~4~/Bi~2~S~3~/Bi~2~O~3~1 g/L300-W Xe lamp(λ\>420 nm)Sulfamethazine (SAZ) and cloxacillin (CLX)10 mg/LApproximately SAZ: 99% and CLX: 90% optimums within 90 min[@b0805]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Z-scheme heterojunctionRGO-Ag~2~O/TiO~2~0.4 g/L350-W Hg lamp (λ\<356 nm), 300-W Xe arc lamp (visible light), 300-W infrared lamp, and 156-W APOLLO solar simulatorTetracycline10 mg/L100% and approximately 100% optimums within 60 min, approximately 90% optimums within 120 min[@b0810]Z-scheme heterojunctionZ-scheme g-C~3~N~4~/Ag~2~CO~3~/graphene oxide0.8 g/L300-W Xe lamp(λ\>420 nm)Tetracycline20 mg/LApproximately 82% optimum within 60 min[@b0815]Z-scheme heterojunctionZ-scheme nitrogen-doped graphene QDs-BiVO~4~/g-C~3~N~4~0.5 g/L250-W Xe lamp(λ\>420 nm)Tetracycline10 mg/LApproximately 91% optimum within 30 min[@b0820]Z-scheme heterojunctionZ-scheme graphitic carbon nitride (CN) and reduced graphene oxide (rGO) with AP 1 g/LBoth intense sunlight and weak indoor light irradiationNorfloxacin10 mg/LApproximately 100% optimum within 30 min and 85% optimum within 2 h[@b0825]Z-scheme heterojunctionZ-scheme WO~3~/Fe~3~O~4~/g-C~3~N~4~1 g/L300-W Xe lamp(λ\>400 nm)Tetracycline20 mg/L89% optimum within 120 min[@b0830]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Z-scheme heterojunctionZ-scheme nitrogen-doped hollow mesoporous carbon spheres (N-HMCs) modified g-C~3~N~4~/Bi~2~O~3~1 g/L300-W Xe lamp(λ\>420 nm)Tetracycline hydrochloride (TCH) and ciprofloxacin hydrochloride (CFH)10 mg/LApproximately 90% and 80% optimum within 60 min[@b0835]Exposing active facetsBi~2~O~2~(OH)(NO~3~) nanosheets with (001) active exposing facets1 g/LUV light irradiation(300-W Hg lamp)Tetracycline hydrochloride10 mg/LApproximately 98% optimum within 25 min[@b0840]Exposing active facetsUltrathin Bi~2~O~2~(OH)~x~Cl~2-x~ solid solution with exposed (001) facets0.5 g/LVisible light(420-nm LED)Ciprofloxacin20 mg/LApproximately 90% optimum within 150 min[@b0845]Exposing active facetsNanosheet BiVO~4~ with oxygen vacancies and exposed (001) facets1 g/L500-W Xe lamp without optical filters to simulate the sunlightOxytetracycline20 mg/LApproximately 96% optimum within 2 h[@b0850]Exposing active facetsVarious well-defined Bi~2~WO~6~ crystals∼ 0.67 g/L300-W Xe lamp(λ\>420 nm)Ciprofloxacin10 mg/LApproximately 70% optimum within 5 h[@b0855]Exposing active facetsDoped BiOCl nanoplates∼ 0.67 g/L300-W Xe lamp (λ\>420 nm)Tetracycline hydrochloride30 mg/LApproximately 90% optimum within 100 min[@b0860]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Exposing active facets(001) Ag\@NC-TiO~2~ square nanosheets1 g/L350-W Xe arc lamp (λ\>420 nm)Ciprofloxacin10 mg/LApproximately 97% optimum within 150 min[@b0865]Exposing active facetsTiO~2~\@g-C~3~N~4~ core-shell quantum1 g/LXe lamp irradiation.Tetracycline20 mg/LApproximately 100% optimum within less than 10 min[@b0870]Porous materialsIntercalate structure g-C~3~N~4~\@ATP1 g/L300-W Xe lamp (λ\>420 nm)Tetracycline20 mg/LApproximately 90% optimum within 2 h[@b0875]Porous materials3D hierarchical mesoporous BiOIOptimum 1.5 or 0.68 g/L1000-W tungsten halogen lamp(λ\>420 nm)Tetracycline hydrochlorideOptimum 2.1 or 2 mg/LApproximately 100% optimum within 37.5 or 101.5 min[@b0880]Porous materialsBiOI hollow microspheres1 g/L300-W Xe lamp (λ\>400 nm)Tetracycline20 mg/L80% optimum within 120 min[@b0885]Porous materialsUltra-thin Bi~2~MoO~6~ nanosheets0.5 g/L-1.5 g/LSunlightOfloxacin10 mg/LApproximately 71% optimum within 90 min[@b0890]Tailoring morphologyRod-like SrV~2~O~6~2-9 g/L500-W tungsten lamp (λ\>400 nm)Metronidazole20 mg/L98% optimum within 60 min[@b0895]**StrategiesCatalysts and concentrationLight sourceAntibiotic and concentrationDegradation efficiencyRef.**Tailoring morphologyTiO~2~ nanobeltsSimulative solar lightAmikacin5 mg/LApproximately 70% optimum within 150 min[@b0900]Tailoring morphologyZnO Nanotubes0.035 g/L300-W Xe lamp (AM1.5 filter (1000 Wm^-2^))Ciprofloxacin6.6 mg/LApproximately 12% optimum within 2 h[@b0905]Tailoring morphologyBi~5~FeTi~3~O~15~0.4 g/L300-W Xe lamp(λ\>420 nm)Tetracycline hydrochloride4.8 mg/LApproximately 99% optimum within 1 h[@b0910]Tailoring morphologyNavel-like Bi~2~WO~6~ hierarchical microspheresUV light irradiation (λ=365 nm)Norfloxacin(Concentration not provided)Approximately 67% optimum within 8 h[@b0915]Tailoring morphologyspearhead-like g-C~3~N~4~Xe lamp(35 W, 6000 K)Tetracycline20 mg/LApproximately 70% optimum within 180 min[@b0920]3D aerogelg-C~3~N~4~\@CA/B-PET5 g/LArtificial solar light(125 mW/cm^2^)Sulfaquinoxaline sodium10 mg/LApproximately 100% optimum within 60 min[@b0925]3D aerogelBiVO~4~/3D RGO aerogel/CeVO~4~0.5 g/L500-W Xe lamp(visible light)Tetracycline20 mg/LApproximately 90% optimum within 120 min[@b0795]3D aerogel3D MoS~2~ nanosheets/graphene aerogel0.8 mg/L300-W Xe lamp(λ\>420 nm)Tetracycline hydrochloride60 mg/LApproximately 10% optimum within 75 min[@b0930]

3.1. Strategies to increase light harvesting {#s0020}
--------------------------------------------

### 3.1.1. Defect engineering to increase light harvesting {#s0025}

Defects play two distinct roles in the photocatalytic process: (1) they act as trapping sites for electrons or holes. Depending on the nature of the defects (deep trap or shallow trap), it may improve the diffusion length of charge carriers (shallow trap) or promote the charge recombination (deep trap) thus reducing the photocatalytic efficiency; (2) they may extend the light absorption by modulating the electronic structure of the photocatalyst (e.g. creation of midgap impurities level), thereby influencing the photocatalytic activity. However, elaborative designs such as vacancy construction and elemental doping are necessary to take full advantage of the improvements and avoid or minimize the disadvantages [@b0935], [@b0940], [@b0945], [@b0950].

#### 3.1.1.1. Vacancies for the improvement of light absorption {#s0030}

Vacancies are types of point defects that not only manipulate the composition of catalysts without introducing impurities but also allow for the customization of suitable band structures by modulating their types and concentrations. The concentration of the vacancies should be controlled within a delicately balanced range. Excessive vacancies would provide too many recombination centers for photoinduced electrons and holes, whereas insufficient vacancies would fail to achieve the desired photocatalytic performance. Vacancies may be categorized into three types: 1) anion vacancies (such as sulfur [@b0955], [@b0960], [@b0965], [@b0970], [@b0975], halogen [@b0980], [@b0985], [@b0990], [@b0995], nitrogen [@b1000], [@b1005], [@b1010] and oxygen vacancies (OV) [@b1015], [@b1020], [@b1025], [@b1030], [@b1035]), 2) cationic vacancies (such as bismuth [@b1040], [@b1045], [@b1050], carbon [@b1055] and titanium vacancies [@b1060], [@b1065], [@b1070], [@b1075]), and 3) mixed vacancies, which combine anion and cation vacancies [@b1080], [@b1085]. For example, mesoporous ZrO~2~ containing abundant oxygen vacancies was successfully synthesized by Zhang *et al*. [@b0260] via a template-less solvothermal approach, following calcination. The absorption edge of the obtained sample was extended into the visible range, and the modified surface characteristics promoted adsorption ability towards organic compounds, leading to an enhancement of the visible-light-driven photodegradation of organic contaminants. Similarly, brown ZnWO~4-x~ nanorods containing oxygen vacancies exhibited a broadened photo-absorption capacity from the ultraviolet (UV) to the near-infrared (NIR) region, whereas conventional white ZnWO~4~ nanorods without OV exhibited a UV absorption onset at 365 nm [@b0270].

[Fig. 3](#f0015){ref-type="fig"} shows the existence of an OV-mid-gap state and three possibilities for electron excitation: (i) UV-driven direct excitation from the VB towards the CB, (ii) visible-light-induced jump from VB to OV defect states, and (iii) near-infrared-light-driven transition from the OV-derived defect state to the CB [@b0270]. The induced defect, or the inter-band energy level, enables electron jumps with less energetic illumination, thereby improving the light harvest capacity of ZnWO~4-x~ nanorods with abundant OV [@b0270]. Moreover, Liu *et al*. [@b1090] reported that anion vacancy could be produced in a TiO~2~ lattice when Ti^3+^ was present. Excess energy levels below the CB would be induced in the presence of these anion vacancies [@b1095], [@b1100], [@b1105], [@b1110]. Overlapping of these levels with CB occurs by increasing the concentration of these vacancies, resulting in a decreased bandgap of TiO~2~. Therefore, the visible-light-driven transition can take place from intrinsic VB to Ti^3+^ states. This behavior can extend the optical response to an onset wavelength of longer than 400 nm [@b1115].Fig. 3Schematic of the OV-induced photocatalytic process on ZnWO~4-x~[@b0270]

#### 3.1.1.2. Heteroatoms or ion doping for light response improvement {#s0035}

The introduction of heteroatoms or ions into the photocatalyst, in the form of dopant, is an effective light response management method. Non-metal dopants (e.g., C [@b1120], [@b1125], B [@b1130], [@b1135], [@b1140], [@b1145], P [@b0285], [@b1150], S [@b1155], [@b1160], N [@b1165], [@b1170], [@b1175], [@b1180], and halogen [@b1185], [@b1190]) and metallic dopants (e.g. Fe^3+^ [@b1195], [@b1200], Ce^3+^ [@b0310], Cr^3+^ [@b1205], W^6+^ [@b1210], Ti^4+^ [@b1215], Cu^2+^ [@b1205], Co^2+^ [@b1220], [@b1225] and Er^3+^ [@b1230]) were most widely studied in semiconductor photocatalysts, especially metal oxides. Generally, a method can either introduce an impurity energy level lower than the CB minimum or higher than the VB maximum to narrow down the bandgap, enhancing light absorption.

Recently, N-doped TiO~2~ photocatalysts with tunable doping contents were prepared by calcining sol-gel TiO~2~ powder in the presence of NH~3~ flow at 450--800 °C [@b1235]. The light absorption capacity of samples prepared at a temperature region of 450--600 °C increased gradually with temperature, and their colors varied from pale yellow to emerald green as a result of the production of N 2p (localized states) beyond the VB of TiO~2~ and the generation of OV ([Fig. 4](#f0020){ref-type="fig"} (a)). When NH~3~ treatment reached T \> 600 °C, anatase TiO~2~ was transformed into rutile, leading to a remarkable reduction in its Brunauer-Emmett-Teller (BET) area and the production of a TiN layer on the TiO~2~ surface. The materials treated at 700 and 800 °C exhibited a conspicuous response to a wide range of spectra spanning from the visible to the NIR range, which originated from the production of OV and Ti^3+^ defects. Similarly, Wang *et al*. [@b1240] synthesized lantern-shaped g-C~3~N~4~ with a Eu^3+^ dopant and found that a doping level was developed below the CB upon the introduction of Eu^3+^, resulting in a narrower bandgap and lowering the electron position compared to that of raw CN. This improved both the optical light response and photocatalytic performance.Fig. 4(a) UV-vis diffuse reflectance spectra of a) 1) raw TiO~2~ (500), and N-TiO~2~ (T) samples prepared at 2) 450, 3) 500, 4) 550, 5) 600, 6) 700 and 7) 800 °C [@b1235], (b) diffuse reflection spectra (DRS) curves of undoped and doped TDHG [@b0315], Inset: Photographs of TDHG, N-TDHG, b -TDHG and b/N-TDHG photocatalysts.

In some cases, co-doping (e.g., the addition of two non-metals [@b0285], [@b1155], two metal ions [@b1230], or a metal ion paired with a non-metal ion [@b0315]) has been used to avoid imbalances of charges during aliovalent doping [@b0935]. For example, b/N-TDHG (black Ti^3+^/N co-doped TiO~2~/diatomite hybrid granule) could be obtained from a sol-gel process [@b0315]. The light absorption of b/N-TDHG ([Fig. 4](#f0020){ref-type="fig"}(b)) exhibited a more pronounced redshift than other TDHG counterparts. Particularly, it had the strongest visible-light response among all obtained photocatalysts, which resulted from the synergistic action of co-doped N and Ti^3+^.

### 3.1.2. Addition of light sensitizers to enhance light absorption {#s0040}

The addition of photosensitizers is another simple method of enhancing the photoactivity of wide bandgap semiconductors in visible light. In recent years, a variety of QDs (e.g., ZnSe QDs [@b0235], carbon QDs (CQDs) [@b0320], [@b0325], [@b0330], [@b0340], [@b0345], [@b1245], [@b1250], [@b1255], [@b1260], [@b1265], graphene [@b1270], CdS [@b1275], [@b1280], Fe~3~O~4~ [@b1285], g-C~3~N~4~ [@b1290], CsPbBr~3~ [@b1295] and MoS~2~ [@b1300]) have been combined into semiconductors to enhance light absorption. Among them, CQDs have become the most widely used QDs to upgrade wide-bandgap semiconductors owing to their low cost, non-toxicity, and high stability [@b1250], [@b1305]. For example, up-converting CQDs were immobilized on the surface of La~2~Ti~2~O~7~ (LTO) nanosheets to promote visible-light-induced photocatalysis [@b1260]. The pristine (i.e., unmodified) LTO nanosheets had no optical response from 400 to 800 nm ([Fig. 5](#f0025){ref-type="fig"} (a)). In contrast, all CQD/La~2~Ti~2~O~7~ (C-LTO) composites exhibited distinct responses in the above range, and the response could be modulated accordingly by changing the amount of CQD.Fig. 5(a) Light absorption curves [@b1260] and (b) photocatalytic mechanisms of CQD/TNT photocatalyst [@b1265]

Zhao *et al*. [@b1265] successfully synthesized TiO~2~ nanotube (CQD/TNTs) composites with an outstanding photocatalytic performance. These CQD co-catalysts had remarkable up-converting photoluminescence (PL) features. Longwave infrared rays (LWIR, \>600 nm) absorption could be converted into optical light of shorter than 600 nm, enabling the production of IR-induced electrons and holes on TNTs ([Fig. 5](#f0025){ref-type="fig"}(b)). Additionally, the introduction of CQDs can accelerate the harvesting of photoexcited electrons and prolong the lifetime of photoinduced carriers.

3.2. Interfacial engineering strategies for carrier migration improvement {#s0045}
-------------------------------------------------------------------------

The construction of a junction interface is a typical approach to facilitate photocatalysis by modulating the separation/migration of the photoinduced electrons and holes at the interface. Therefore, in-depth studies have been conducted to design photocatalyst junction interfaces to monitor carrier migration capabilities. According to their phase composition, junction interfaces can be divided into homogenous junction interfaces and heterojunction interfaces.

### 3.2.1. Homogenous junction interfaces {#s0050}

Homogenous junction interfaces are built by identical compounds in the absence of additional components and have been the focus of significant interest. The construction of homogenous junction interfaces is primarily based on the established phase junction or facet junction, creating an effective migration pathway for the photoinduced charges.

### 3.2.2. Phase junction {#s0055}

Most crystals (e.g., TiO~2~ [@b1310], [@b1315], [@b1320], [@b1325], [@b1330], [@b1335], [@b1340], [@b1345], [@b1350], CdS [@b1355], Bi~2~O~3~ [@b1360], MoS~2~ [@b1365] and ZnIn~2~S~4~ [@b1370]) have many different natural or artificial phases. The construction of the phase junction is a significant approach to improve the photocatalytic performance through accelerating the migration of electrons and holes. Many studies have been conducted on the design of photocatalyst phase junctions to boost carrier migration characteristics and capabilities [@b1375], [@b1380]. Jia *et al*. [@b1385] studied the theoretical basis of the phase changes and interfacial characteristics of Cu~2~ZnSnS~4~ with a hetero-phase junction. A type-II band structure could be formed at the hetero-phase junction of (101), (110), and (100) facets, thereby facilitating the photoelectric capacity. However, type-I heterojunctions may be aligned at the phase junction of (112) and (001) facets, hindering the generation of charges and improving optoelectronic properties owing to a high potential barrier. Similarly, according to the band engineering design theory, a bonding-region-width-controlled phase junction surrounded by cubic CdS and a hexagonal counterpart was designed by Ai *et al*. [@b1355]. The electron--hole separation was optimized at an appropriate bonding region width (0.76 nm), which exhibited the highest photocatalytic efficiency (45% quantum efficiency) among all the examined samples, in addition to good photocorrosion resistance.

Artificial phases caused by vacancies or self-doping have been used to construct a phase junction to control the separation of electrons and holes. Recently, Cao *et al*. [@b1005] constructed a g-C~3~N~4~ p-n homojunction through introducing nitrogen vacancies (NVs). The differences in Mott-Schottky plots between bulk g-C~3~N~4~ (CN) and PN-2 indicated that the conductivity characteristics of the homojunction were consistent with a p-n model ([Fig. 6](#f0030){ref-type="fig"} (a) and (b)). Additionally, the PN-2 homojunction exhibited a distinct improvement in its photocatalytic performance to treat Rhodamine B (RhB), compared to CN, which was attributed to the efficient separation of the photoexcited charges at the PN-2 homojunction ([Fig. 6](#f0030){ref-type="fig"}(c) and (d)). Chade Lv *et al*. [@b1390] synthesized Bi^5+^-BVO (Bi^5+^-self-doped Bi~4~V~2~O~11~) nanotubes and formed p-n homojunctions by implementing the oxygen vacancy strategy. Density functional theory (DFT) simulations and laboratory findings reveal that Bi^5+^ auto-doping reduces the bandgap of Bi~4~V~2~O~11~ (BVO), thereby enhancing light capture. Furthermore, Bi^5+^ auto-doping confers both n- and p-type semiconductor characteristics to BVO, which enables the construction of p-n homojunctions to delay the quick annihilation of electrons and holes.Fig. 6Mott-Schottky curves on (a) CN and (b) PN-2; (c and d) schematic of carrier migration at the p-n homojunction [@b1005]

### 3.2.3. Facet engineering {#s0060}

Previous studies have reported that, unlike isolated surfaces, the coexistence of multiple crystal planes in single particles could be recognized as interactive surfaces with synergistic effects [@b1395], [@b1400]. This means that redox reactions occur locally at the separate planes, resulting in spatial charge separation in semiconductors. For example, multi-morphologic silver bromide (AgBr) crystals containing distinct exposed planes were prepared by synchronously injecting silver nitrate and potassium bromide precursors [@b0370]. The shape and exposed planes of the target sample could be easily modulated by varying the density of Br^-^ ions, which can significantly reduce the surface barrier of (100) and (111) planes and affect their growth rates. C-AgBr ((100) facet exposed cubes), T-AgBr ((100) and (111) facet exposed tetradecahedrons), and O-AgBr ((111) facet exposed octahedrons) could be obtained at specific Br^-^ concentrations of 10^0^, 10^0.5^, and 10^1^ mM. The obtained T-AgBr exhibited improved photocatalytic performance for the degradation of methyl orange (MO) and sulfadiazine (SD) owing to the formed facet heterojunction structures between the (111) and (100) facets. When irradiated with optical light, the electrons and holes are separately transported to the (100) and (111) facets. Therefore, electrons and holes could not merely be efficiently separated, but back-reaction was effectively prevented owing to the isolation of active redox sites.

### 3.2.4. Heterojunction interfaces {#s0065}

The formation of homojunctions is considerably challenging owing to its complexity and high cost. Therefore, the creation of heterojunction interfaces has been proposed as an alternative to improve charge separation efficiency and has been widely investigated in the past decades [@b1405]. Typically, heterojunctions are divided into five categories: (1) Schottky heterojunctions, (2) type I heterojunctions, (3) type II heterojunctions, (4) p-n heterojunctions, and (5) Z-scheme heterojunctions.

### 3.2.5. Schottky heterojunctions {#s0070}

At the semiconductor-metal interface, photoinduced electrons may typically flow from the former to the latter to match their Fermi energies and form a Schottky barrier. The formed Schottky junction can efficiently capture the electron, which promotes electron-hole separation. To further comprehend the mechanisms by which the Schottky junction improves photocatalysis, He *et al.* [@b1410] prepared a series of Schottky-junction Ag-loaded carbon nitride fibers (Ag/CNFs) through loading NaBH~4~-reduced Ag on preformed CNFs. The Schottky-type Ag/CNFs exhibited outstanding photodegradation performance for tetracycline (TC) under visible irradiation. The enhanced photodegradation activity resulted from the synergistic effect between surface plasmon resonance (SPR) on silver nanoparticles (Ag NPs) and the efficient isolation of the photoinduced carriers at the constructed Schottky heterojunction. Moreover, on account of the SPR absorption of specific metals, the light response could even be extended to the entire sunlight range. Therefore, in addition to promoting charge separation, semiconductors and plasmonic metals could also jointly improve light harvesting.

Jiang and co-workers synthesized a novel Ag/Bi~3~O~4~Cl photocatalyst with different amounts of Ag via a facile photo-deposition process [@b0395]. The TC degradation on 1.0 wt% Ag/Bi~3~O~4~Cl was drastically more pronounced, compared to pristine Bi~3~O~4~Cl, and 94.2% TC could be degraded in 120 min ([Fig. 7](#f0035){ref-type="fig"} (a)). The improved photocatalytic properties resulted from the synergism of the photoinduced electrons on Bi~3~O~4~Cl and SPR from Ag NPs, which improved visible-light harvesting and facilitated the isolation of photoinduced electrons and holes ([Fig. 7](#f0035){ref-type="fig"}(b)).Fig. 7(a) Photodegradation of TC by the as-synthesized plasmonic Ag/Bi~3~O~4~Cl under visible irradiation, (b) possible photocatalytic mechanisms on the Ag/Bi~3~O~4~Cl samples [@b0395], (c) photocatalytic kinetics of prepared g-C~3~N~4~, Pt/g-C~3~N~4~, Au/g-C~3~N~4~, and Au/Pt/g-C~3~N~4~ nanocomposites [@b0430] (d) schematic of the g-C~3~N~4~ photoinduced charge transport [@b1420]

In other studies, bimetallic-supported semiconductor catalysts (Pt/Au/TiO~2~ [@b1415], [@b1420], Au/Ag/TiO~2~ [@b1425], Pd-Cu/TiO~2~ [@b1430] and Ag-Cu/TiO~2~ [@b1435]) exhibited super activity and high selectivity, which cannot be found in single metals owing to the synergistic effect of bimetals. For example, Xue et al. [@b0430] prepared plasmonic Au/Pt/g-C~3~N~4~ via a simple calcination-photo-deposition process. The prepared heterostructure photocatalyst exhibited an optimized photodegradation performance for antibiotic tetracycline hydrochloride (TC-HCl) treatment, and the visible-light-driven degradation was 3.4 times higher than that of pristine g-C~3~N~4~ ([Fig. 7](#f0035){ref-type="fig"}(c)). This enhanced photodegradation performance was attributed to the synergism between the SPR absorption on Au and the electron-trap effect of Pt NPs, which facilitated the light-harvesting capability and isolation of photoinduced charges on g-C~3~N~4~, thereby jointly boosting the photocatalytic properties. Similarly, TiO~2~ nanotube arrays (Au-Pt/TNTAs) with small quantities of Au-Pt were successfully prepared. Notably, these structures exhibited remarkably enhanced visible-light harvesting and carrier separation capacity. These enhancements in photodegradation activity derived from the synergism from interfacial Schottky junctions and the synergistic effect between ternary Au, Pt, and TNTAs ([Fig. 7](#f0035){ref-type="fig"}(d)) [@b1420].

### 3.2.6. Type I or II heterojunctions {#s0075}

Compared to single semiconductors, the formation of type I semiconductor heterojunctions can promote photocatalytic efficiency. However, electrons and holes are enriched on the same semiconductor, which cannot effectively restrain the recombination of photoinduced electrons and holes. This makes type I semiconductor heterojunctions questionable prospects for photocatalytic property improvement [@b1440], [@b1445]. To date, large numbers of traditional type II heterojunctions have been intensively investigated, some of which have rendered drastically optimized photocatalysis performances. For example, compared to pristine MgFe~2~O~4~, newly synthesized MgFe~2~O~4~/MoS~2~ heterojunctions can accelerate electron--hole dissociation, albeit without extending the light-harvesting scope [@b0450]. The as-synthesized MgFe~2~O~4~/MoS~2~ sample delivered a prominent photoelectrochemical performance in TC treatment and H~2~ evolution owing to its unique bandgap structure. In another study, a novel 2D-2D thin-layered g-C~3~N~4~/Bi~4~O~5~Br~2~ type II heterojunction was synthesized by Ji's group [@b0570] through a simple ionic-liquid-assisted solvothermal process ([Fig. 8](#f0040){ref-type="fig"} ). This 2D g-C~3~N~4~ component had a layered microstructure, providing enough potential to successfully build intense interface interactions with exfoliated Bi~4~O~5~Br~2~ nanosheets. Implementing the 2D layered g-C~3~N~4~ component provided several clear advantages, including an enlarged specific surface area (SBET), broadened optical light harvesting range, optimized electron--hole separation, and accelerated transport of the interfacial electrons and holes, all of which enhanced the photocatalytic performance of the Bi~4~O~5~Br~2~ system within a given light range.Fig. 8Preparation process for g-C~3~N~4~/Bi~4~O~5~Br~2~ nanocomposites [@b0570]

### 3.2.7. p-n heterojunction {#s0080}

Schottky and type II heterojunctions may successfully split electron--hole pairs. However, it is still necessary to restrain the superfast electron--hole annihilation at the interface. Therefore, p-n heterojunctions have been implemented and widely used to manage photocatalytic properties. For instance, Kang *et al*. [@b0590] constructed a high-performance CoO/g-C~3~N~4~ p-n junction through a simple solvothermal process. The prepared p-n junction exhibited excellent visible-light-induced photocatalytic properties and consistency for TC treatment. These excellent photocatalytic properties were attributed to the production of an interfacial electric field around the junction, which effectively prevented the annihilation of photo-induced charges. Furthermore, a SnO~2~/BiOI n-p heterojunction was successfully achieved by Wen *et al.* [@b0620] by depositing SnO~2~ NPs onto the outer surface of BiOI nanosheets. The obtained n-p heterojunction exhibited a strong visible-light-driven photocatalysis capacity and durability for the degradation of MO and oxytetracycline HCl. This excellent photocatalytic activity resulted from the constructed p-n heterojunction, which significantly limited the annihilation of electrons and holes.

Similarly, a novel three-dimensional (3D) layered BiOBr/Bi~2~SiO~5~ p-n heterostructure was successfully synthesized to efficiently degrade TC [@b0615]. The prepared BiOBr/Bi~2~SiO~5~ p-n heterostructure exhibited an optimized visible-light-driven photocatalytic degradation of TC, which was 3.6-fold higher than that of BiOBr. Moreover, this high TC photodegradation performance remained constant for 5 cycles. This optimized photodegradation property of the BiOBr/Bi~2~SiO~5~ heterostructure was ascribed to the following factors: (1) the introduced BiOBr facilitated light harvesting within a broad optical range, and (2) the formed p-n heterojunction restrained the annihilation of photoinduced electrons and holes. These features prominently promoted the generation of ·OH, ·O~2~ ^-^, and H^+^, leading to a promoted photocatalytic activity.

### 3.2.8. Z-scheme heterojunction {#s0085}

The development of Z-scheme photocatalysis was inspired by photosynthetic systems in nature and has attracted tremendous interests since the first report of a conventional Z-scheme photosystem in 1979 ([Fig. 9](#f0045){ref-type="fig"} (a)) [@b1450], [@b1455]. Depending on the charge transport route involved, Z-scheme photosystems are classified as conventional, all-solid-state, and direct, which are distinguished by the specific transport medium used to facilitate the charge transport of reversible redox ion pairs, electronic conductors, and direct interfacial contacts, respectively [@b1455], [@b1460], [@b1465], [@b1470], [@b1475]. For example, Ma et al. prepared a Z-scheme WO~3~/K^+^Ca~2~Nb~3~O~10~ ^-^ binary 2D-2D heterojunction photocatalyst from a facile hydrothermal co-assembly method at ambient conditions [@b0735]. The as-prepared WO~3~/K^+^Ca~2~Nb~3~O~10~ ^-^ photocatalyst exhibited a remarkable improvement in the photodegradation of TC-HCl under simulated sunlight irradiation, compared to pristine WO~3~ and K^+^Ca~2~Nb~3~O~10~ ^-^. 20%-WO~3~/K^+^Ca~2~Nb~3~O~10~ ^-^ exhibited the maximum activity, which was 5.1 and 2 times higher than those of WO~3~ and K^+^Ca~2~Nb~3~O~10~ ^-^, respectively. These enhanced properties and sustainability were attributed to the tightly-coupled heterointerfaces, increased SBET area, optimized optical-capturing capability, and improved carrier dynamics of the semiconductor in the Z-scheme procedure.Fig. 9(a) Roadmap of Z-scheme photocatalytic system evolution [@b1465]; (b) suggested photoinduced charge transport on g-C~3~N~4~(60)/TNTAs [@b1480]

Yang *et al*. [@b0775] designed a new Z-scheme heterostructure Ag\@AgI/VI-BOI (iodine-vacancy-rich BiOI), whereby Ag\@AgI NPs were loaded locally on the outer surface of defect-rich BiOI nanosheets. This Z-scheme heterostructure possessed a remarkable visible-light-induced photocatalysis capacity for TC treatment, which was significantly higher than those of pristine BiOI, VI-BOI, and Ag\@AgI. The enhanced photocatalytic properties of this Z-scheme heterostructure originated from the synergistic action between VI (iodine vacancies), interface junctions between AgI and VI-BOI, and Ag^0^. A direct visible-light-induced solid-state C~3~N~4~ NS/TNTAs (g-C~3~N~4~ nanosheet/TiO~2~ nanotube array) Z-scheme heterostructure ([Fig. 9](#f0045){ref-type="fig"}(b)) was successfully fabricated in-situ by adding preformed g-C~3~N~4~ nanosheets into the anodizing bath solution [@b1480]. Enhanced photocatalytic performances and good stability were observed on nanosheet-supplemented photocatalysts, and g-C~3~N~4~(60)/TNTAs exhibited an optimum activity for the degradation of rhodamine B (RhB) and colorless TC-HCl. The optimized photodegradation performance was derived from an enhanced light harvesting capacity, a suppressed carrier recombination, and an extended carrier lifetime.

### 3.2.9. Double heterojunction {#s0090}

In addition to heterojunctions, double heterojunctions such as QDs Schottky heterojunctions combined with type II, Z-scheme heterojunction [@b0635], [@b0650], [@b0655], [@b0660], type I combined with Z-scheme heterojunctions, and double Z-scheme heterojunctions have been applied to treat antibiotics (e.g., tetracycline hydrochloride, ciprofloxacin, oxytetracycline, ciprofloxacin, etc.) in water [@b0675]. Tang *et al.* [@b1485] prepared ternary Ag/CuNb~2~O~6~/CuFe~2~O~4~ heterostructures. The prepared multicomponent heterostructures exhibited stronger visible-light-induced photodegradation properties towards methylene blue (MB) and the pesticide imidacloprid than their single (CuNb~2~O~6~) and binary (Ag/CuNb~2~O~6~ or CuNb~2~O~6~/CuFe~2~O~4~) counterparts. The excellent photodegradation performance of the obtained ternary heterostructure was attributed to an enhanced visible-light harvesting capacity and rapid charge recombination restraint.

Jo *et al.* [@b0650] developed a novel ternary 2D/2D/2D-configured LDH/CN/RGO heterostructure (CoAl-layered double hydroxide/g-C~3~N~4~/reduced graphene oxide) from a simple one-step hydrothermal synthesis. The prepared LDH/CN/RGO heterostructure exhibited a significantly superior visible-light-induced photodegradation activity for the treatment of Congo red (CR) and TC in water. Particularly, the LDH/CN/RGO heterostructure containing RGO (1 wt.%) and LDH (15 wt.%) featured optimum photodegradation properties in all the synthesized photocatalysts. The significantly enhanced photodegradation efficiency and outstanding consistency of the heterostructure LDH/CN/RGO were primarily attributed to the intense interface interaction between the CN, LDH, and RGO components ([Fig. 10](#f0050){ref-type="fig"} ). This strong interfacial effect was further facilitated by the specifically arranged 2D/2D/2D microstructure, which ultimately accelerated the charge transport at the interface and efficiently separated photoinduced electrons and holes.Fig. 10Photocatalytic degradation mechanisms of CR and TC by a ternary LDH/CN/RGO heterostructure [@b0650]

3.3. Strategies to manage surface reactions {#s0095}
-------------------------------------------

Although charges can be effectively separated, recombination in the process of electron transport remains problematic when the charges cannot be consumed promptly due to low activity or limited active sites on the semiconductor surface. Therefore, strategies have been proposed to promote intrinsic active sites on photocatalysts and the adsorption of pollutants.

### 3.3.1. Selective exposure of high energy facets {#s0100}

Typically, the redox reactions that occur on the outer surface or interface of semiconductors are highly susceptible to the exposed facets. Based on crystal anisotropy data, it is widely known that different crystal facets have different atomic arrangements, which result in different physical and chemical properties, including anisotropic surface electronic structures, tunable surface energy, and diverse molecule absorption abilities and reactivities [@b1395].

Hao *et al*. [@b0840] synthesized Bi~2~O~2~(OH)(NO~3~) nanosheets (BON-NS) with a predominant exposure of the reactive (001) plane through a wet-chemical process using sodium dodecylbenzene sulfonate (SDBS) as a template. They found that the BON-NS samples consisted of loosely stacked nanosheets, which provided an exceptionally high specific surface area, as well as more efficient charge separation. This feature was likely derived from the dominant exposure of reactive (001) facet and the \[Bi~2~O~2~(OH)\]^+^ stacking layers down the *c* axis, which induces the orientation of an auto-built electric field. This allows the developed BON-NS to have an elevated capability for carrier separation and migration, leading to significantly superior UV-light photocatalysis performance for the treatment of antibiotics (tetracycline hydrochloride) than their bulk counterparts [@b0840]. Additionally, hexagonal WO~3~ (h-WO~3~) was synthesized by employing sodium sulfate and ammonium sulfate as end-capping reagents through diverse hydrothermal methods [@b1490]. Particularly, h-WO~3~ NSs with exposed (002) planes exhibited the highest visible-light photodegradation performance owing to their large BET surface and interior electron--hole separation on high-energy (002) reactive planes.

### 3.3.2. Preparation of 2D porous materials {#s0105}

Porous materials have numerous notable advantages, including a high-density active core that facilitates photocatalytic reactions, high light absorption rates derived from the reflection and scattering of incident light within the pores, and high specific surface areas that improve the adsorption of contaminants and accelerate surface reactions.

Two-dimensional (2D) materials, including black phosphorus (BP), transition metal dichalcogenides (TMDs), metal oxides, metal carbides, metal nitrides, hexagonal boron nitride (h-BN), g-C~3~N~4~, and layered double hydroxides (LDH), have attracted substantial interest in the field of photocatalysis [@b1495], [@b1500], [@b1505]. When performing as photocatalysts, the high BET surface and abundant surface reactive sites of 2D candidates may result in enhanced catalytic activity. To further improve photocatalytic properties, 2D porous materials with a more accessible BET surface and additional reactive sites are developed to completely expose the active sites to the contaminants and participate in the oxidation-reduction process, which degrades the contaminants and produces H~2~/O~2~.[@b1510] Unfortunately, 2D porous materials, such as MoSe~2~ [@b1515], [@b1520], MoS~2~ [@b1525], [@b1530], [@b1535], and g-C~3~N~4~ [@b1540], [@b1545], [@b1550], [@b1555], [@b1560], [@b1565], [@b1570], [@b1575], [@b1580], [@b1585], [@b1590], [@b1595], [@b1600], [@b1605], [@b1610] are mostly used in photocatalytic hydrogen evolution or photodegradation of organic dyes and are rarely applied for the degradation of antibiotics. Nonetheless, 2D porous materials could be promising candidates for the photocatalytic treatment of antibiotics.

Kang *et al*. [@b1555] prepared few-layer g-C~3~N~4~ NSs with foamy pores by ultrafast liquid-N~2~-frozen exfoliation of its bulk counterpart within 10 s. The foamed porous super-thin g-C~3~N~4~ NSs exhibited interesting advances such as well-crystallized characteristics, a narrowed energy band, an additional unveiled edge, a slightly-augmented BET surface (135.6 m^2^/g) with an increased mesopore, and an enhanced charge transport capability. Unlike massive g-C~3~N~4~, the super-thin porous g-C~3~N~4~ exhibited a remarkably promoted capability to generate reactive oxygen species (ROS) and a 4-fold improvement in performance for visible-light-excited RhB decomposition. This primarily resulted from an increase in reactive sites and a shortened route for charge transport. These results suggest that this technology could be further developed to generate high-performance super-thin g-C~3~N~4~ NSs for contaminant treatment.

Template-free 2D porous super-thin g-C~3~N~4~ NSs with doped oxygen atoms were synthesized by She *et al*. [@b1580]. The photodegradation performance (60.8%) of MO and the mean H~2~ production speed (∼189.3 μmol·h^-1^) were nearly 71 and 5.2 times higher than those in the bulk phase, respectively. This enhanced photocatalysis derived from unique features such as an enriched adsorbable/reactive site, a reinforced oxidation-reduction capability and enhanced charge migration.

### 3.3.3. Preparing 3D aerogel materials {#s0110}

Aerogel photocatalysts with 3D continuous network structures can provide ultra-large accessible surface areas, rich porosities, and a large number of photocatalytic active sites, which can result in high absorption capacity and enhanced photocatalytic performance. Moreover, 3D aerogel materials can solve the problem of dispersion and recovery of photocatalytic materials in practical applications [@b0930]. Liu *et al.* [@b0795] recently fabricated ternary CeVO~4~/3D RGO (reduced graphene oxide) aerogel/BiVO~4~ photocatalysts ([Fig. 11](#f0055){ref-type="fig"} ) and used them for visible-light-induced O~2~ generation and TC removal. The synthesized aerogel composites displayed a well-defined 3D hierarchical microstructure built by the two vanadates and RGO. The optimum heterostructure exhibited a significantly facilitated visible-light-excited H~2~O oxidation capacity as well as TC degradation. This optimized photocatalysis capacity resulted from the large BET surface and ternary Z-scheme heterojunction of the aerogel. These features enabled the 3D RGO aerogel to connect to the other semiconductors and act as distinct dual pathways to further enhance the charge transport.Fig. 11Synthesis of BiVO~4~/RGO/CeVO~4~ heterostructures [@b0795]

A freestanding MoS~2~ nanosheets/graphene aerogel (3D MoS~2~ NS/GA) heterostructure was recently created through a simple hydrothermal process [@b0930]. The obtained 3D MoS~2~ NS/GA exhibited an excellent visible-light photodegradation efficiency for TC-HCl disposal with superior stability and reusability. Chen *et al*. [@b0925] prepared powerful cellulose aerogel/blended polyester fibers (3D g-C~3~N~4~\@CA/B-PET) via a simple process by supporting g-C~3~N~4~ NSs on B-PET reinforced cellulose aerogel (CA). The prepared g-C~3~N~4~\@CA/B-PET photocatalyst exhibited a superior photocatalytic performance to treat sulfaquinoxaline sodium and Cr (VI), compared to pristine g-C~3~N~4~. Moreover, heterostructure g-C~3~N~4~\@CA/B-PET aerogel can be easily recycled and reused and is remarkably resistant to light and water currents.

4. Summary and outlook {#s0115}
======================

The hazards of antibiotics and their treatment methods were briefly discussed herein, followed by a discussion on the current state of photocatalytic degradation of antibiotics in water. Photocatalysis plays an important role in treating antibiotic residues in water due to its superb features. However, efforts have to be made to further improve the efficiency for the wide application of this technology. The strategies for the improvement of degradation efficiency are the following:(1)increasing light-harvesting capacity via defect engineering(2)enhancing charge separation via interface engineering

\(3\) accelerating surface reaction.

These strategies are promising based on previous studies. However, for further practical applications, many challenges remain to be addressed:a)It is difficult to identify the exact occurrence, formation, concentration, and types of defects (especially for vacancies) using current characterization techniques. This produces barriers for understanding the relationship between the structure and performance, which limits the further development of these technologies.b)The construction of traditional heterojunctions via interface engineering has been intensively studied. Nonetheless, only a few previous studies have focused on homojunctions and double heterojunctions, given that current preparation methods are complex, time-consuming, non-eco-friendly, and theoretically lacking.c)The BET surface and the number of active sites of a catalyst are key factors for accelerating surface reactions. In addition to increasing the specific surface area by controlling catalyst morphology, the selective exposure of highly active high-specific-surface-area crystal faces has recently become a popular research topic. However, most of these materials are used for hydrogen production, with few instances of antibiotic treatment applications.

Despite these challenges, this review provides valuable information on improvement and modification strategies for the design of high-performance photocatalysts to treat antibiotic residues in water. Besides, it is difficult to treat the antibiotic residues in practice by a sole technology. Innovating a complex system comprising photocatalysis and photoelectrocatalysis or electrocatalysis could be a promising alternative for the efficient removal of antibiotic residues in water. This review provides new insights into the design of high-efficiency photocatalysts for the degradation of antibiotic residues, thereby furthering the development of photocatalysis for water treatment and other fields.
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